Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chapman, Sherita N, Mehndiratta, Prachi, Johansen, Michelle C, McMurry, Timothy L, Johnston, Karen C, Southerland, Andrew M
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://ncbi.nlm.nih.gov/pubmed/24591838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39213
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars